PHARMACYCLICS $81.86

down -3.03


20/5/2013 04:20 PM  |  NASDAQ : PCYC  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
12 Mo. Price Change : 186% - PCYC has outperformed the S&P 500 by 158%

Get Trend Analysis Icon Get Trend Analysis

Partner Headlines

  1. Earnings Scheduled For February 14, 2013

    Benzinga

  2. Pharmacyclics Granted Breakthrough Therapy Designation from FDA ...

    Benzinga

  3. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga

  4. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga

  5. Top 100 Stocks Of 2012 Include Builders, Biotech, 3D

    Investors Business Daily

  6. Short Interest Swings in Biotech Stocks (CELG, GILD, REGN)

    Benzinga

  7. Pharmacyclics Presents Positive Data at American Society of ...

    Benzinga

  8. UPDATE: Dawson James Initiates Pharmacyclics at Market Outperform ...

    Benzinga

  9. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    Investors Business Daily

  10. Short Interest Swings in Biotech Stocks (AMGN, BIIB, VRTX)

    Benzinga

  11. Pharmacyclics

    Investors Business Daily

  12. Mid-Afternoon Market Update: Markets Rally, Vringo Jumps

    Benzinga

  13. Mid Morning Market Update: Markets Decline, Stifel Financial ...

    Benzinga

  14. Earnings Scheduled For November 5, 2012

    Benzinga

  15. Benzinga's Top Initiations

    Benzinga

  16. UPDATE: Piper Jaffray Initiates Pharmacyclics at Buy

    Benzinga

  17. Short Interest Swings in Biotech Stocks (BIIB, GILD, VVUS)

    Benzinga

  18. Short Interest in Biotech Firms Resumes (BIIB, GILD, ILMN, REGN)

    Benzinga

  19. UPDATE: Wedbush Securities Reiterates Outperform Rating, Raises PT ...

    Benzinga

  20. Pharmacyclics

    Investors Business Daily

  21. Pharmacyclics, Inc. Reports Operating Results (10-K)

    GuruFocus

  22. Short Interest in Biotech Firms on the Rise

    Benzinga

  23. UPDATE: Stifel Nicolaus Initiates Pharmacyclics at Hold; Valuation ...

    Benzinga

  24. Ebay, Toll Brothers Among Stocks Hitting 52-Week Highs Wednesday

    FOXBusiness

  25. Best Buy, Public Storage Among Stocks Down on High Volume Monday

    FOXBusiness

  26. UPDATE: Rodman & Renshaw Raises PT to $75 on Pharmacyclics on ...

    Benzinga

  27. Pharmacyclics Triggers Significant Milestone Payment For Mantle ...

    Benzinga

  28. Target, Constellation Brands Among Stocks Hitting 52-Week Highs ...

    FOXBusiness

  29. Financial Breakfast: Morning News Summary for August 1, 2012

    Benzinga

  30. Pharmacyclics® Triggers Significant Milestone Payment and Provides ...

    Benzinga

  31. Biotechs In Motion As New Drug Pipeline Brims

    Investors Business Daily

  32. Health Care Sector Wrap

    FOXBusiness

  33. Dendreon, Pharmacyclics and Other Biotech Takeover Targets

    Benzinga

  34. Are Pharmacyclics Bulls Buying Options Insurance?

    By SchaeffersResearch

  35. Health Care Sector Wrap

    FOXBusiness

  36. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FOXBusiness

  37. Arena Pharmaceuticals, Pharmacyclics Included in Stocks Up on High ...

    FOXBusiness

  38. Arena Pharmaceuticals, Merck &, Other Stocks Hit 52-Week Highs ...

    FOXBusiness

  39. Pharmacyclics, Choice Hotels International Among Stocks Setting ...

    FOXBusiness

  40. UPDATE: Wedbush Reiterates Outperform, Raises PT to $55 on ...

    Benzinga

  41. Pharmacyclics (PCYC) Gains 5% on Positive Drug Trial Data

    At Market Intelligence Center

  42. Pharmacyclics® Announces Updated Results for BTK Inhibitor ...

    Benzinga

  43. DSW, Pharmacyclics, Other Stocks Hit 52-Week Highs Tuesday

    FOXBusiness

  44. Social Media Outlook for Thursday 17 (PCYC, DRI, MLM, SPLS)

    Benzinga

  45. Options Sellers Eye Pharmacyclics' Longer-Term Puts

    By SchaeffersResearch

  46. Honda, Movado and Others Analysts Are Bullish On

    Benzinga

  47. Pharmacyclics Earnings Report Sparks Put-Selling Activity

    By SchaeffersResearch

  48. Pharmacyclics (PCYC) Gains 2.3%, Continuing Friday's Rally

    At Market Intelligence Center

  49. Pharmacyclics Inc. Reports Operating Results (10-Q)

    at GuruFocus

  50. Rodman & Renshaw Maintains Outperform, $22 PT on Pharmacyclics

    at Benzinga

  51. Rodman & Renshaw Comments on Pharmacyclics, Maintains PT

    at Benzinga

  52. Rodman & Renshaw Maintains Market Outperform on Pharmacyclics

    at Benzinga

  53. Rodman & Renshaw Maintains Outperform, $20 PT on Parmacyclics

    at Benzinga

  54. Edison Investment Research Comments on Pharmacyclics

    at Benzinga

  55. Pharmacyclics Announces Updated Results for BTK Inhibitor ...

    at Benzinga

  56. Pharmacyclics Reports Interim Phase II Trial Results for BTK ...

    at Benzinga

  57. Stocks Finish Week with Gains on Europe's New Deal

    At Market Intelligence Center

  58. End-of-Day Market Summary for December 9, 2011

    at Benzinga

  59. Afternoon Movers; Positive Euro News

    at Benzinga

  60. Global Hunter Downgrades Pharmacyclics to Neutral

    at Benzinga

  61. RBC Capital Downgrades Pharmacyclics to Sector Perform

    at Benzinga

  62. Rodman & Renshaw Initiates Pharmacyclics at Market Outperform, $20 PT

    at Benzinga

  63. Options Players Take a Shine to Pharmacyclics Calls

    By SchaeffersResearch
People viewing PCYC also viewed: , , , , , ,
Marketplace
Trading Center